AKT1 and neoplasm: The study has proved that the treatment of mice with β-sitosterol decreased tumor growth by lowering PI3K/Akt expression, promoting Bad activation, decreasing Bcl-xl, and increasing cytochrome-c release, resulting in caspase-9 and caspase-3 activation, PARP cleavage, and apoptosis.